Skip to main content
PTIX
OTC Life Sciences

Protagenic Therapeutics 10-K: Going Concern, Nasdaq Delisting, and $7.3M Unwind Gain

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.36
Mkt Cap
$651.675K
52W Low
$0.128
52W High
$6.2
52W Position info
181% above low
Off High info
94% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PTIX has more than doubled off its 52-week low of $0.128 on light trading volume (0.2× avg).

Summary

Protagenic Therapeutics filed its 10-K, disclosing a going concern warning, Nasdaq delisting, material weaknesses, and a $7.3M gain from unwinding its Phytanix Bio merger.


Key Events · Earnings and Guidance · PTIX

  • Going Concern Warning

    Cash of $1.5M as of March 31, 2026, funds operations only through Q3 2026. The company needs additional capital within 12 months.

  • Nasdaq Delisting

    Common stock delisted from Nasdaq effective January 5, 2026, now trading on OTCQB. Company is evaluating steps to regain compliance.

  • Material Weaknesses

    Management identified material weaknesses in internal controls over financial reporting, including lack of segregation of duties and ineffective risk assessment.

  • Phytanix Bio Unwind

    Reverse merger with Phytanix Bio was unwound on February 17, 2026, resulting in a $7.3M gain on disposal of subsidiary.


Analysis · PTIX · Life Sciences

The annual report reveals a going concern warning with cash only through Q3 2026, material weaknesses in internal controls, and delisting from Nasdaq. The company also unwound its reverse merger with Phytanix Bio, recognizing a $7.3M gain, and implemented a restructuring plan to cut $8M in annual expenses. These are critical disclosures for a micro-cap biotech with a $0.36 stock price.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PTIX was trading at $0.36 on OTC in the Life Sciences sector, with a market capitalization of approximately $651.7K. The 52-week trading range was $0.13 to $6.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PTIX - Latest Insights

PTIX
Nov 11, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.49345
Real-time Price: $0.460 info
Change: -$0.03345 (-7%) info
Market Cap: $832.696K info
PTIX
Aug 20, 2026, 11:26 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.400
Real-time Price: $0.460 info
Change: +$0.060 (+15%) info
Market Cap: $832.696K info
PTIX
Aug 19, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.350
Real-time Price: $0.460 info
Change: +$0.110 (+31%) info
Market Cap: $832.696K info
PTIX
Apr 06, 2026, 7:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.530
Real-time Price: $0.460 info
Change: -$0.070 (-13%) info
Market Cap: $832.696K info
PTIX
Mar 09, 2026, 7:51 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.4211
Real-time Price: $0.460 info
Change: +$0.0389 (+9%) info
Market Cap: $832.696K info